| Valiant Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543998 |
NSE Symbol : VALIANTLAB |
P/E(TTM) : - |
|
ISIN Demat : INE0JWS01017 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 52.91 |
Market Cap(₹Cr) : 504.24 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 21.48 | 18.88 | 30.58 | 40.52 | 59.55 | 51.41 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 21.48 | 18.88 | 30.58 | 40.52 | 59.55 | 51.41 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.93 | 2.17 | 2.50 | 1.78 | 2.96 | 2.44 |
| Total Income | 23.41 | 21.06 | 33.09 | 42.29 | 62.51 | 53.85 |
| Total Expenditure | 28.22 | 21.27 | 35.11 | 46.82 | 60.93 | 47.59 |
| PBIDT | -4.81 | -0.21 | -2.03 | -4.53 | 1.57 | 6.26 |
| Interest | 0.01 | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 |
| PBDT | -4.81 | -0.27 | -2.05 | -4.55 | 1.55 | 6.24 |
| Depreciation | 0.51 | 0.50 | 0.50 | 0.49 | 0.49 | 0.46 |
| Tax | -0.09 | 0.09 | -1.58 | -1.34 | 0.50 | 1.43 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.75 | 0.15 | 0.25 | -0.21 | -0.23 | 0.08 |
| Reported Profit After Tax | -5.98 | -1.01 | -1.22 | -3.50 | 0.79 | 4.27 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -5.98 | -1.01 | -1.22 | -3.50 | 0.79 | 4.27 |
| EPS (Unit Curr.) | -1.39 | -0.23 | -0.32 | -0.81 | 0.24 | 1.31 |
| EPS (Adj) (Unit Curr.) | -1.39 | -0.23 | -0.32 | -0.81 | 0.24 | 1.31 |
| Calculated EPS (Unit Curr.) | -1.38 | -0.23 | -0.28 | -0.81 | 0.24 | 1.31 |
| Calculated EPS (Adj) (Unit Curr.) | -1.38 | -0.23 | -0.28 | -0.81 | 0.24 | 1.31 |
| Calculated EPS (Ann.) (Unit Curr.) | -5.51 | -0.93 | -1.12 | -3.23 | 0.97 | 5.24 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -5.51 | -0.93 | -1.12 | -3.23 | 0.97 | 5.24 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.45 | 43.45 | 43.45 | 43.45 | 32.56 | 32.56 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -22.39 | -1.11 | -6.64 | -11.18 | 2.64 | 12.18 |
| PBDTM(%) | -22.39 | -1.43 | -6.70 | -11.23 | 2.60 | 12.14 |
| PATM(%) | -27.84 | -5.35 | -3.99 | -8.64 | 1.33 | 8.31 |